Erba expands into US with $6.5m Escalon Dx acquisition
This article was originally published in Clinica
German in vitro test kit manufacturer Erba Diagnostics has bought Escalon Medical's clinical diagnostics business for $6.5 million in cash, giving it a footprint in the US. The deal also provides Erba with new testing capabilities, as well as a business that brought in $13 million in the 12 months ending 30 June. Mannheim-based Erba currently specialises in OEM products including clinical, haematology, urine and electrolyte analysers; and ELISA devices, and reagents and accessories. It has a presence in Latin America, Europe, Africa, Russia, the Middle East and Asia. Escalon's diagnostic business comprises Drew Scientific (Dallas, Texas), which produces glycated haemoglobin (HbA1c) analysers for diabetes monitoring and haematology instruments; and JAS Diagnostics (Miami Lakes, Florida), which specialises in a range of liquid stable diagnostic chemistry reagents for OEM use.